AI assistant
DEXCOM INC — Director's Dealing 2018
Aug 29, 2018
30198_dirs_2018-08-28_26c22050-a3e4-4986-8a6f-dc8a2750f77b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-08-24
Reporting Person: ALTMAN STEVEN R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-24 | Common Stock | S | 5000 | $136.4718 | Disposed | 0 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3449 | Direct |
| Common Stock | 57855 | Indirect |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $136.47 to $136.56. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: Shares held by The Lisa and Steve Altman Family Foundation with respect to which the reporting person is an authorized agent.
F3: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.